Paper Details
- Home
- Paper Details
Perils of prolonged ovarian suppression and hypoestrogenism in the treatment of breast cancer: Is the risk of treatment worse than the risk of recurrence?
Author: CastracaneV Daniel, KauffmanRobert P, YoungChristina
Original Abstract of the Article :
Premenopausal breast cancer is usually estrogen receptor positive, and hence, prolonged ovarian suppression by medical or surgical means to prevent recurrence has become standard of management to improve disease-free survival. Ten-year adjuvant tamoxifen therapy is associated with 3.5% fewer recurre...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/j.mce.2021.111181
データ提供:米国国立医学図書館(NLM)
Prolonged Ovarian Suppression: Navigating the Complexities of Breast Cancer Treatment
Breast cancer, a formidable desert landscape, requires a carefully planned strategy for treatment. This study, like a wise guide navigating the complexities of breast cancer management, examines the potential risks and benefits of prolonged ovarian suppression in premenopausal women. The researchers, like skilled cartographers, explore the impact of prolonged hypoestrogenism on both cancer recurrence and overall health.
Balancing Risks and Benefits: A Delicate Equation in Breast Cancer Treatment
The study highlights the delicate balance between reducing cancer recurrence and preserving long-term health in premenopausal breast cancer patients. While prolonged ovarian suppression can significantly reduce the risk of recurrence, it can also lead to a range of adverse effects related to hypoestrogenism, such as cardiovascular disease, bone loss, and cognitive decline.
Personalized Treatment Strategies: A Path Towards Better Outcomes
This research, like a beacon guiding towards a more personalized approach, underscores the need for individualized treatment plans for premenopausal breast cancer patients. By carefully weighing the risks and benefits of prolonged ovarian suppression, clinicians can develop treatment strategies that optimize outcomes while minimizing long-term health consequences.
Dr.Camel's Conclusion
This study, like a map illuminating the intricate pathways of breast cancer treatment, emphasizes the importance of balancing the risks and benefits of prolonged ovarian suppression. The findings provide valuable insights for developing personalized treatment strategies that prioritize both cancer control and long-term well-being.
Date :
- Date Completed 2021-10-06
- Date Revised 2021-10-06
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.